chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive. The patient got sick within 18 hours of getting the booster vaccine. The patient and her daughter have had this; tested positive. The patient got sick within 18 hours of getting the booster vaccine. The patient and her daughter have had this; This is a spontaneous report received from non-contactable reporter (Nurse). Other Case identifiers: MOD22-029141 on behalf of Moderna).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (batch/lot number: unknown) for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive. The patient got sick within 18 hours of getting the booster vaccine. The patient and her daughter have had this". The patient underwent the following laboratory tests and procedures: COVID-19 test: (unspecified date) positive; (08Nov2022) unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The reporter informed that the patient was still tested positive. The patient got sick within 18 hours of getting the booster vaccine. The patient and her daughter have had this, they live together. They both tested Tuesday 08Nov2022, but they didn't get the result until today 10Nov2022. The patient wanted to know if she was still contagious. She was still holding on to a little bit of the cough, but she didn't feel sick. The patient informed that her daughter feels good. The patient stated that her daughter got the Pfizer on the same exact day that the patient got her Moderna vaccines. The patient informed that she was told by her doctor that if she was testing positive, then that means she was still shedding virus. She was told by another nurse that she could have the virus up to 3 months in her body, but she was not contagious.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: A contributory role of BNT162B2 to event tested positive/ The patient got sick within 18 hours of getting the booster vaccine/The patient and her daughter have had this cannot be excluded based on temporal association and available information.
pt recvd vax; devel redness, pain, 10x20cm region of induration around inject site; no sxs; sl inc t 99; n x 2 days;
Reaction to influenza vaccine; s/s: itching, flushing, nasal inflammation. Pt reports going to E.R to address s/s, shortly after as our office closed at 5pm.
Bell palsy develop Wednesday early morning some numbness in lip but condition worsen around 7pm at night, face droop, blurred vision , and paralysis set in. Thursday seen dr and started  prednisone 20mg tablet , 2 tablet once a day and valtrex 20mcg , 3 times daily .  Currently a week on meds and symptoms hasn?t improved. Never been diagnosed with bell palsy or have any neuroconditions.  Blurred vision and paralysis is still the same.  Have some eyelid and mouth movement.
Prickly Papular rash first noted on left flank area and knees. The "rash" stayed to those areas for several days then slowly spread all over. There was no redness to her skin for about the first two weeks. Her face, feet, and hands were the last affected areas. Once the papules reached her face, hands, and feet, it became more inflamed and angry red when her skin was irritated/warm/bathed. Her outer thighs were the most dense areas. As of today, her skin is still covered in papules, but do appear to be slowly decreasing in size.
He then 'came down with COVID'; He then 'came down with COVID'; This is a spontaneous report from a contactable consumer (patient).   A 64-year-male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 09Sep2021, at single dose, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, in 2021, after the first dose, the patient experienced COVID-19 described as "He then 'came down with covid' and was treated with Regeneron and 'now he is negative'". The patient recovered from the adverse event on an unspecified date, in 2021.   The lot number for BNT162B2, was not provided and will be requested during follow up.
Immediate post vaccine fell to floor and had approximate 15 second petit mal seizure. When became conscious, stated that before fall left arm felt numb and she felt funny. She also said that she had not eaten that day.
Was briefly hospitalized for suspected Anaphylaxis, reported nausea, increased heart rate, dizziness.
Fever off/on for roughly 48 hours.  Fever was about 102 and seemed to respond to both Advil and Tylenol which were given alternately over the course of the 48 hour period.  Baby was fussy at night - waking up every couple of hours but reasonably happy during the day despite off/on fever.  Over the phone nurse consultation made us both feel it was a vaccine reaction since there were no other symptoms.
Initial report received from a pt, who is a veterinarian, on 7/25/05. This 58 year old male pt reported that he had received a set of vaccinations on 7/8/05, TD, IPOL, MMR, Hepatitis A, Hepatitis B, the lot numbers of all the vaccines were unknown. On 7/12/05 he started biting inside of cheeks and tongue. He developed sores that are clearing up. On 7/21/05, he presented with prickly rash on his right knee. Then, on 7/22/05, he had rash to both elbows and knuckles. He has not seen DR. At the time of reporting, the pt did not recover. Follow up received on 10/3/05 as per the additional information, it was stated that the client reported symptoms 13-14 days after the vaccination on 7/8/05. Lot numbers for IPOL and Tetanus and Diphtheria Toxoids absorbed for Adult use were X1212 and U1341AA respectively. He had also received a Rabies booster and Hepatitis A&B vaccine on 8/12/05. The pt was not still recovered at the time of the report.
Roughly 3 weeks after my first Covid vaccine I started to get a cough, chest started hurting, runny nose, headache and fever
Patient received 3 immunizations at 7:15 pm on September, 27, 2019. He woke up at 1:15 am on September 28 ,2019 and went to the bathroom. When he returned to bed he had trouble breathing . It continued to get worse. He tried to sleep on his side and continued to get worse. He sat up in bed. At 1 :30 am he went downstairs and sat at his table and continued to get worse, shortness of breath , could not catch his breath and felt like he was being smothered. He called his wife and told he her that he  needed to go the the ER. He arrived at the ER AT 1:50 am and was immediately given an IV of Benadryl, solu-medrol and an albuterol breathing treatment.  His pulse ox was 86 and he was tachycardic. He brought 3 prescription to me at 9 am on September, 28. Prednisone 20 mg 1 bid #10, benadryl 25 mg 1 q 6 h #20, zyrtec 10mg  1 qd #5
Fever; tiredness; left armpit nodule swelling; very warm on vaccination area; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6072) via an unspecified route of administration, administered in Left arm on 21Mar2021 (at the age of 43 year old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient was not pregnant at the time of vaccination. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number unknown, via an unspecified route of administration on 28Feb2021 1:00 (at the age of 43 year old), as single dose for COVID-19 immunization. Prior vaccination, patient did not receive any other vaccines within 4 weeks and was not diagnosed with COVID-19. On an unspecified date, the patient experienced fever, tiredness, left armpit nodule swelling, and very warm on vaccination area. Since the vaccination, the patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
The area around the site of injection had a rash, redness and mild swelling that extended approximately 4 inches down from the injection site.
Case number PHEH2014US020847 is an initial spontaneous report received from a pharmacist on 16 Oct 2014. This case refers to a 22 year old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with an expired dose of MENVEO (batch number: M12098 and expiry date: not reported) intramuscularly on 16 Oct 2014. No adverse event was reported following this administration error (expired vaccine used).
This child was given Pfizer Bivalent 12 and up dose (0.3ml) instead of Pfizer Bivalent 5-11 years (0.2ml)
pt recvd vax 17JUN92 & exp an erythema multiforme like rash on both thighs, fever of 100 & dec appetite; seen in office 23JUn; treatment included DPH & prelone for 3 days;  25JUN rash has disappeared; pt asymptomatic;
mild fatigue; didn't feel as motivated; The initial case was missing the following minimum criteria: unspecified adverse effect. Upon receipt of follow-up information on 20Apr2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a Pfizer sponsored program support from a contactable consumer (patient). This case refers to dose 2 experience. A 58-year-old male patient received the second dose of bnt162b2 (Pfizer COVID 19 vaccine, lot number: ER8734, Expiry Date: 31Jul2021) via intramuscular in right arm on 05Apr2021 at single dose for COVID-19 immunization. The patient's medical history included autoimmune condition. The patient's concomitant medications included ongoing azathioprine (IMURAN) 150mg by mouth daily and prednisone 7mg orally daily, both for autoimmune condition.  The patient previously received the first dose of bnt162b2 (Pfizer COVID 19 vaccine, lot number: EP6955, Expiry Date: 30Jun2021) via unspecified route of administration in left arm on 15Mar2021 at single dose for COVID-19 immunization and experienced felt like someone punched him in the arm about 12 hours after. The patient stated when he went to get his second dose he noticed there was still a black and blue mark on his left arm from where he had the first shot and this was 21 days later, so he decided to get the second shot in his right arm. He did not end up with a black and blue mark for an extended period of time with the second dose. The patient stated the second shot didn't really feel any real symptoms at all, maybe some mild fatigue he noticed when he was working out the day after. The patient stated he didn't feel as motivated and it lasted only a day. The patient experienced mild fatigue; didn't feel as motivated from 06Apr2021 to 07Apr2021. On 19Apr2021, the doctor ordered a SARS-COV-2 IgG antibody test and it came back negative with SARS COV2 IgG index of 0.02. The patient stated he wanted to know was that the appropriate test that was run, asked if he had an immune response. The patient stated that he didn't want to run around with a false sense of security.  The outcome of the events was resolved.   No Follow-up attempts are needed. No further information is expected. ; Sender's Comments: Linked Report(s) :  Same patient, different dose and event.
very sore arm at injection site for 2 days.  For 4 days had no appitite and felt nausous.  I had chills and night sweats and a low grade fever.I was tired and foggy and not myself.
Initial misuse report received from a healthcare professional on 04 October 2013. The patient had received expired FLUZONE. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
High fever; chest pain; back pain; This is a spontaneous report from a contactable consumer. A 35-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: FC3182 and expiration date was not reported), dose 2 via intramuscular route of administration in left arm on 25Aug2021 at 15:00 (age at vaccination 35-years-old) as single dose for COVID-19 immunization. The patient medical history included Anorexia. The patient's concomitant medications were not reported. The historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: FA7484 and expiration dates were not reported), dose 1 via an intramuscular route of administration in left arm on 04Aug2021 at 15:00 pm as single dose for COVID-19 immunization. No other vaccine in four weeks and no other medications in two weeks. On 26Aug2021 at 02:30 PM the patient experienced high fever, chest pain and back pain. The Adverse event resulted in Emergency room/department or urgent care. The patient treated with the Tylenol for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was reported as withheld. The outcome of the events was recovering.  Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.
Adverse event is a SARS-CoV-2 infection at approximately 6 months post vaccination.   I had two doses of Pfizer-BioNTech vaccine (first on 4/18/2021, second on 5/9/2021).   And yet by 11/23/2021 I tested positive for SARS-CoV-2 and was experiencing side effects of the virus.  On 11/22/2021 I wrapped up a week of inability to work with a day of no ability to even move from bed. The  full week before I was falling asleep 4-6 hours ahead of bedtime. And for at least a week before I had a runny nose that was so irritated that I had to hack up crap from my throat every morning and it was not a pretty color (yellow/green) and it was this set of symptoms that led me to seek medical advice. I originally believed I simply had a sinus infection but it turned up to be SARS-CoV-2. Something that should NOT have happened.
Moderna 1st vaccine on 4/15/21: Headache right after first dose. Developed Covid Arm 7 days after first dose. Moderna 2nd dose on 5/15/21: Right facial numbness/tingling 12 hours after second dose.
Information has been received from a physician concerning his 24 year old daughter with no pertinent medical history reported and no known drug allergies, who "about six weeks ago" (on approximately 04-MAY-2009) was vaccinated with first dose of GARDASIL (dose, route and lot number not reported).  Concomitant therapy included PROZAC during the week she had premenstrual syndrome.  "The same day of vaccination" (on approximately 06-MAY-2009), the patient fainted and developed vomiting, diarrhea and dizziness.  The patient recovered from fainted, nausea and vomiting, diarrhea and dizziness "about three days after vaccination" (on approximately 07-May-2009).  No lab studies were performed.  The patient sought unspecified medical attention.  Fainted, nausea and vomiting, diarrhea and dizziness were considered to be disabling by the physician because the patient missed work.  Additional information has been received from the physician who reported that he would not be supplying any more information about his daughter's event.  Since his daughter had received the vaccine and experienced the event at come clinic in another city, he did not have the vaccine date, lot number or adverse event onset date.  The healthcare professional contacted during the telephone follow up call could not supply the following information: date of vaccination, lot number or date of event.  Additional information is not expected.
Allergic reaction; I felt some very light tingling on my face,; My cheeks got little blushed; it felt like inside my nostrils it got closed up a little bit; This is a spontaneous report from a contactable consumer (Patient himself).    A 61-year-old male patient received first dose of BNT162B2 (BNT162B2 Formulation: Solution for injection Batch/Lot Number: EN6207 Expiration Date: Unknown) via an unspecified route of administration, in Arm Left on 23Mar2021 (at the age of 61-year-old) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 23Mar2021, the patient Stated that she wanted to report a very slight allergic reaction to vaccine that she received last week and she thought it was best to do it here. Patient stated, "About the half hour after the shot she felt some very light tingling on her face, her cheeks got little blushed and it felt like inside her nostrils it got closed up a little bit, she was allergic to beestings but she never had a reaction to medicine or a vaccine that she was known of before. she did not break out in hives or rash, no fever, no trouble breathing or anything like that she would say these symptoms lasted less than an hour and said it was very minor. Second due date of vaccine: 16Apr2021. No treatment received. Outcome of events was recovered on an unspecified date in Mar2021.  No follow up attempts are possible. No further information is expected.
The patient reported her face started to get red and hot about 5 to 10 minutes after the vaccine was administered. She also stated she felt slightly dizzy. I had the patient seated for about 5 minutes and gave her water. The mom stated the patient gets anxious while getting vaccines and this could've been from that. After 5 minutes, I checked on the patient again and the redness on her face had gone down, and she also stated she felt a little better. I had the patient seated for another 10 minutes just in case. The redness on her face did decrease while she was seated, and she stated her face no longer felt hot. I gave the patient Benadryl and she stayed for another 5 minutes before her mom stated she was feeling better. I counseled the mom on which symptoms to monitor for and to seek medical attention if symptoms return and worsen. I followed up with the parent the next couple days via phone and did not hear anything back.
CHILD DOB DISPLAYED AS 7/14/2008  AND AGE WRITTEN AS 12 ON CONSENT FILLED OUT BY INDIVIDUAL INDENTIFYING AS GRANDFATHER. Immunization Registry INDICATES CHILDS DOB AS 7/14/2009, MAKING CHILD TOO YOUNG TO RECEIVE VACCINE IN 5/2021.
light headed noted after vaccine with pt getting juice. Pt BP 97/60  98% HR 67. Pt felt better as well
Pregnancy and vaccinated; This spontaneous prospective pregnancy case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy and vaccinated) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asthma since an unknown date. Concomitant products included VITAMINS NOS.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 05-Oct-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy and vaccinated). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy and vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided
Chills and nasal congestion progressing throughout the afternoon to wheezing with mild pain and inflammation at injection site. During the evening hours, advanced redness and swelling with pain around injection site. Large hive like raised (approx. size of apple) area around injection site. Skin around injection site hot to touch and very tender. Low grade fever of 100 on morning of 11/05/2011. Difficulty using right arm with increased wheezing/upper respiratory congestion with right eye severely bloodshot. Refused to be seen by physician at local urgent center clinic Sat. 11/05/2011. Will contact Clinic Monday in AM. Will go to emergency room if condition or symptoms become severe. At home on bed rest until then.
This case was reported by a consumer and described the occurrence of fever in a 2 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix).  A physician or other healthcare professional has not verified this report.  On 03/25/2004, the patient inadvertently received simultaneous doses of Infanrix in the right and left hip for the first two doses of the Infanrix series.  This is sooner than the recommended interval of 4 to 8 weeks between the first and second doses.  The lot number for the Infanrix dose in the left hip is DTPA616A2.  At an unspecified time following the administration of Infanrix, on 03/25/2004, the patient experienced fever and was seen at a physician's office.  She was treated with acetaminophen and the fever resolved on 03/26/2004.
Redness (L) arm, warm to touch seen by MD today returned pt back to clinic.
Patient started feeling dizzy, nauseous, and was pale within 5 minutes of the vaccination. Was able to carry a normal conversation and able to drink water. No labored breathing. Did not appear to develop hives. No Epi-Pen or Benadryl administered. Initially declined ambulance, but requested one within 15 minutes of vaccination. Paramedics arrived at 3:30pm, patient exhibiting no improvement or worsening of symptoms.
Information has been received from a pharmacist concerning a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 16-DEC-2016, the patient received a dose of unexpired ZOSTAVAX (dose, lot # and expiration date were not reported) that was prepared with expired sterile diluent  (manufacturer unknown) (lot# L001646, expiration date 20-DEC-2015) subcutaneously for prophylaxis. No known adverse effects. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA014393: US-009507513-1612USA014391: US-009507513-1612USA014321.